Roe: Lowest-cost FDA-approved GLP-1 treatment options · Jul 9–14, 2026

Active
Roe

Roe provides low-cost options for FDA-approved GLP-1 treatment, countering the assumption that such medications are unaffordable.

Jul 9, 2026
First seen
Jul 14, 2026
Last seen
3
Reads
1
Shows
1
Active months
1:07
Avg. length

13-week activity

Public campaign reads by observed week

through Aug 13
1
2

Renewal signals

30 dayNo
60 dayPending
90 dayPending
Promo-code persistence

No recurring promo code was observed.

Core offer

Lowest-cost FDA-approved GLP-1 treatment options

Shows

Where the campaign appeared

Placements

mid-roll3

Categories

Representative reads

Examples across the campaign

Example transcript

The read that best represents this campaign's recurring script

View promo
THE ED MYLETT SHOW·John Maxwell's #6 Law of Leadership: The Law of Solid Ground
Est. value ~$450range $72$3K
Hey, guys, we're sponsored by Roe. And I got to tell you, a lot of people assume GLP-1s cost a fortune. And that's the assumption that keeps them even for looking into the treatment. But the reality is there may be a more affordable option. way more affordable than people realize. Rho helps people find the low-cost path to FDA-approved GLP-1 treatment, whether that's through insurance coverage or just cash pay options that are more accessible than expected. I gotta tell you, GLP-1s have become known for their results, but also for like sky-high prices, so there's just a certain class of people that can afford it, and that's not right, and it's actually not true. What I love about Rho is they wanna help people lose weight, bottom line, and that's why they have the lowest-cost options out there, whether you're paying with insurance or cash, like I said. And here's all I can tell you guys, I use this and I think you should too. So go to roe.co slash my let to see if you qualify. That's ro.co slash my let to get started on Roe. Go to roe.co slash safety for box warning and full safety information about GLP-1 medications.

These signals describe observed podcast advertising activity. Per-read dollar figures are directional current placement proxies—not historical campaign spend, reach, conversions, or return on investment.